SARS-CoV-2 infected European people with R708W, R710C, R710H, or R716C substitutions in ACE2 usually have mild symptoms of COVID-19 as ACE2 lose the cleavage site which is the target of the TMPRSS2 protease (Hou et al., 2020). The gene discussed is ACE2; the disease is COVID-19.